The PennZone

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Accelerate Diagnostics, Inc. ("Accelerate" or the "Company") (NASDAQ: AXDX) investors concerning the Company's possible violations of federal securities laws.

On October 21, 2022, after the market closed, Accelerate disclosed that it had received a request from the U.S. Food and Drug Administration to immediately discontinue the marketing and distribution of its Accelerate Arc system and related BC Kit for a particular diagnostic use.

On this news, Accelerate's stock fell $0.62, or 39%, to close at $0.97 per share on October 24, 2022, thereby injuring investors.

If you purchased Accelerate securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

More on The PennZone

• Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton
• Ashley Russo Receives Linny Lifetime Achievement Award
• How to Choose a Heating Repair Company in Philadelphia
• Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
• Lehigh County Drug and Alcohol Celebrates Grand Opening of Journeys

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

---

Show All News | Disclaimer | Report Violation